Generate a tailored SOP for Dr. Michael Falster. Improve your application with a focused, well-structured draft.
Michael Falster is an Associate Professor at UNSW Sydney specializing in the use of population-level data and advanced analytics to evaluate healthcare outcomes within the Australian health system. He leads the Cardiometabolic Medicines Research Stream in the Medicines Intelligence Research Program and holds the position of Deputy Director Research within the School of Population Health. His research interests encompass optimizing treatments for individuals with complex cardiovascular, metabolic, and renal health conditions, as well as improving the uptake of best-practice cardio-renal medicines among high-risk populations. Michael's work emphasizes identifying and addressing disparities in healthcare access and outcomes for both publicly and privately funded patients. His contributions include shaping national reporting and informing models of primary care through significant research funded by the National Health and Medical Research Council (NHMRC) and the Heart Foundation. His early career was marked by a PhD that explored hospitalizations deemed potentially preventable, which has influenced national health performance indicators. He is dedicated to utilizing big data to enhance healthcare delivery and quality for Australians.
University of New South Wales • Sydney, Australia
Leads research initiatives in population health focusing on cardiometabolic medicine.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.